Yunhui Liu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Yunhui Liu has a total of 68 co-authors. Here are the top co-authors by number of shared publications:
- Fan Yang
Guangdong Provincial Key Laboratory of Brain Connectome and Behavior, Shenzhen-Hong Kong Institute of Brain Science, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen, China
11 shared publications - Liping Wang
Shenzhen Key Laboratory of Viral Vectors for Biomedicine, Shenzhen-Hong Kong Institute of Brain Science, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen 518055, China
7 shared publications - Jie Shao
Guangdong Provincial Key Laboratory of Brain Connectome and Behavior, the Brain Cognition and Brain Disease Institute, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences
4 shared publications - Lu Zhang
The Brain Cognition and Brain Disease Institute, Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences, Shenzhen, China
4 shared publications - Dashuang Gao
The Brain Cognition and Brain Disease Institute, Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences, Shenzhen-Hong Kong Institute of Brain Science-Shenzhen Fundamental Research Institutions, Shenzhen 518055, China
3 shared publications - Guangyuan Li
Beijing Institute of Technology
3 shared publications
Latest Publications
- Open Access
- 6 October 2025
- Published by American Chemical Society (ACS) in Chemical & Biomedical Imaging
- Vol. 4 (3) , 394-401
All-Dielectric Metasurface-Enhanced Fluorescence for Probing Mitochondrial Membrane Potential Dynamics
Fluorescence probes are the primary tools for monitoring mitochondrial membrane potential (MMP), a key indicator of mitochondrial function and cellular health. Although metasurfaces offer significant potential for enhancing fluorescence biosensing, all-dielectric metasurfaces with their inherent advantages remain largely unexplored for this application. Here, we demonstrate a fluorescence probe for MMP dynamics, significantly enhanced by an all-dielectric metasurface. Designed to support bound states in the continuum (BICs) via folded Brillouin zones, this metasurface achieves both a high quality factor and strong near-field enhancement. Experiments reveal an order-of-magnitude fluorescence intensity enhancement for cells on the metasurface compared to those off it, irrespective of forskolin stimulation. This approach enables dynamic monitoring of cellular health through MMP fluctuations at subthreshold concentrations.
- 6 October 2025
- Published by American Chemical Society (ACS) in Chemical & Biomedical Imaging
- Vol. 4 (3) , 394-401
Open AccessAll-Dielectric Metasurface-Enhanced Fluorescence for Probing Mitochondrial Membrane Potential Dynamics
Fluorescence probes are the primary tools for monitoring mitochondrial membrane potential (MMP), a key indicator of mitochondrial function and cellular health. Although metasurfaces offer significant potential for enhancing fluorescence biosensing, all-dielectric metasurfaces with their inherent advantages remain largely unexplored for this application. Here, we demonstrate a fluorescence probe for MMP dynamics, significantly enhanced by an all-dielectric metasurface. Designed to support bound states in the continuum (BICs) via folded Brillouin zones, this metasurface achieves both a high quality factor and strong near-field enhancement. Experiments reveal an order-of-magnitude fluorescence intensity enhancement for cells on the metasurface compared to those off it, irrespective of forskolin stimulation. This approach enables dynamic monitoring of cellular health through MMP fluctuations at subthreshold concentrations.
- 18 January 2025
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 749, 151362
Chemogenetic modulation of parathyroid hormone secretion alleviates osteoporosis in ovariectomized rats
- 18 January 2025
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 749, 151362
Chemogenetic modulation of parathyroid hormone secretion alleviates osteoporosis in ovariectomized rats
- 5 August 2024
- Published by Wiley in Advanced Optical Materials
- Vol. 12 (22)
Homogeneous and Significant Near‐Field Enhancement in All‐Dielectric Metasurfaces for Sensing Applications (Advanced Optical Materials 22/2024)
- 5 August 2024
- Published by Wiley in Advanced Optical Materials
- Vol. 12 (22)
Homogeneous and Significant Near‐Field Enhancement in All‐Dielectric Metasurfaces for Sensing Applications (Advanced Optical Materials 22/2024)
- 19 April 2024
- Published by Wiley in Advanced Optical Materials
- Vol. 12 (22)
Homogeneous and Significant Near‐Field Enhancement in All‐Dielectric Metasurfaces for Sensing Applications
All‐dielectric metasurfaces supporting high‐Q resonances have emerged as a promising platform for sensing applications. However, the greatly enhanced near‐fields are usually confined within the all‐dielectric nanostructures rather than the outside analyte region, severely limiting the bulk sensitivity and the biosensing performance. Here, a silicon metasurface formed by the hybridization of two lattices with a relative displacement is designed to support nonlocal quasi‐bound states in the continuum (q‐BICs) featuring homogeneous and significant near‐field enhancement over large volumes outside the silicon nanodisks. A high bulk sensitivity of 407 nm RIU–1 is experimentally demonstrated for the refractive index sensing applications, and a limit of detection down to 20 pg mL–1 for a protein biomarker for the early‐stage breast cancer screening, which is improved by more than an order of magnitude over the state of the art. It is expected that the nonlocal q‐BICs open new opportunities for realizing greatly enhanced light–matter interactions over large volumes in applications beyond biochemical sensing.
- 19 April 2024
- Published by Wiley in Advanced Optical Materials
- Vol. 12 (22)
Homogeneous and Significant Near‐Field Enhancement in All‐Dielectric Metasurfaces for Sensing Applications
All‐dielectric metasurfaces supporting high‐Q resonances have emerged as a promising platform for sensing applications. However, the greatly enhanced near‐fields are usually confined within the all‐dielectric nanostructures rather than the outside analyte region, severely limiting the bulk sensitivity and the biosensing performance. Here, a silicon metasurface formed by the hybridization of two lattices with a relative displacement is designed to support nonlocal quasi‐bound states in the continuum (q‐BICs) featuring homogeneous and significant near‐field enhancement over large volumes outside the silicon nanodisks. A high bulk sensitivity of 407 nm RIU–1 is experimentally demonstrated for the refractive index sensing applications, and a limit of detection down to 20 pg mL–1 for a protein biomarker for the early‐stage breast cancer screening, which is improved by more than an order of magnitude over the state of the art. It is expected that the nonlocal q‐BICs open new opportunities for realizing greatly enhanced light–matter interactions over large volumes in applications beyond biochemical sensing.
- Open Access
- 22 March 2022
- Published by Springer Nature in Molecular Psychiatry
- Vol. 27 (6) , 2901-2913
Cav3.1-driven bursting firing in ventromedial hypothalamic neurons exerts dual control of anxiety-like behavior and energy expenditure
The central nervous system has evolved to coordinate the regulation of both the behavior response to the external environment and homeostasis of energy expenditure. Recent studies have indicated the dorsomedial ventromedial hypothalamus (dmVMH) as an important hub that regulates both innate behavior and energy homeostasis for coping stress. However, how dmVMH neurons control neuronal firing pattern to regulate chronic stress-induced anxiety and energy expenditure remains poorly understood. Here, we found enhanced neuronal activity in VMH after chronic stress, which is mainly induced by increased proportion of burst firing neurons. This enhancement of VMH burst firing is predominantly mediated by Cav3.1 expression. Optogenetically evoked burst firing of dmVMH neurons induced anxiety-like behavior, shifted the respiratory exchange ratio toward fat oxidation, and decreased food intake, while knockdown of Cav3.1 in the dmVMH had the opposite effects, suggested that Cav 3.1 as a crucial regulator. Interestingly, we found that fluoxetine (anxiolytics) could block the increase of Cav3.1 expression to inhibit the burst firing, and then rescued the anxiety-like behaviors and energy expenditure changes. Collectively, our study first revealed an important role of Cav3.1-driven bursting firing of dmVMH neurons in the control of anxiety-like behavior and energy expenditure, and provided potential therapeutic targets for treating the chronic stress-induced emotional malfunction and metabolism disorders.
- 22 March 2022
- Published by Springer Nature in Molecular Psychiatry
- Vol. 27 (6) , 2901-2913
Open AccessCav3.1-driven bursting firing in ventromedial hypothalamic neurons exerts dual control of anxiety-like behavior and energy expenditure
The central nervous system has evolved to coordinate the regulation of both the behavior response to the external environment and homeostasis of energy expenditure. Recent studies have indicated the dorsomedial ventromedial hypothalamus (dmVMH) as an important hub that regulates both innate behavior and energy homeostasis for coping stress. However, how dmVMH neurons control neuronal firing pattern to regulate chronic stress-induced anxiety and energy expenditure remains poorly understood. Here, we found enhanced neuronal activity in VMH after chronic stress, which is mainly induced by increased proportion of burst firing neurons. This enhancement of VMH burst firing is predominantly mediated by Cav3.1 expression. Optogenetically evoked burst firing of dmVMH neurons induced anxiety-like behavior, shifted the respiratory exchange ratio toward fat oxidation, and decreased food intake, while knockdown of Cav3.1 in the dmVMH had the opposite effects, suggested that Cav 3.1 as a crucial regulator. Interestingly, we found that fluoxetine (anxiolytics) could block the increase of Cav3.1 expression to inhibit the burst firing, and then rescued the anxiety-like behaviors and energy expenditure changes. Collectively, our study first revealed an important role of Cav3.1-driven bursting firing of dmVMH neurons in the control of anxiety-like behavior and energy expenditure, and provided potential therapeutic targets for treating the chronic stress-induced emotional malfunction and metabolism disorders.
- Open Access
- 9 February 2022
- Published by Springer Nature in Nature Communications
- Vol. 13 (1) , 1-17
An optogenetic approach for regulating human parathyroid hormone secretion
Parathyroid hormone (PTH) plays crucial role in maintaining calcium and phosphorus homeostasis. In the progression of secondary hyperparathyroidism (SHPT), expression of calcium-sensing receptors (CaSR) in the parathyroid gland decreases, which leads to persistent hypersecretion of PTH. How to precisely manipulate PTH secretion in parathyroid tissue and underlying molecular mechanism is not clear. Here, we establish an optogenetic approach that bypasses CaSR to inhibit PTH secretion in human hyperplastic parathyroid cells. We found that optogenetic stimulation elevates intracellular calcium, inhibits both PTH synthesis and secretion in human parathyroid cells. Long-term pulsatile PTH secretion induced by light stimulation prevented hyperplastic parathyroid tissue-induced bone loss by influencing the bone remodeling in mice. The effects are mediated by light stimulation of opsin expressing parathyroid cells and other type of cells in parathyroid tissue. Our study provides a strategy to regulate release of PTH and associated bone loss of SHPT through an optogenetic approach.
- 9 February 2022
- Published by Springer Nature in Nature Communications
- Vol. 13 (1) , 1-17
Open AccessAn optogenetic approach for regulating human parathyroid hormone secretion
Parathyroid hormone (PTH) plays crucial role in maintaining calcium and phosphorus homeostasis. In the progression of secondary hyperparathyroidism (SHPT), expression of calcium-sensing receptors (CaSR) in the parathyroid gland decreases, which leads to persistent hypersecretion of PTH. How to precisely manipulate PTH secretion in parathyroid tissue and underlying molecular mechanism is not clear. Here, we establish an optogenetic approach that bypasses CaSR to inhibit PTH secretion in human hyperplastic parathyroid cells. We found that optogenetic stimulation elevates intracellular calcium, inhibits both PTH synthesis and secretion in human parathyroid cells. Long-term pulsatile PTH secretion induced by light stimulation prevented hyperplastic parathyroid tissue-induced bone loss by influencing the bone remodeling in mice. The effects are mediated by light stimulation of opsin expressing parathyroid cells and other type of cells in parathyroid tissue. Our study provides a strategy to regulate release of PTH and associated bone loss of SHPT through an optogenetic approach.
- Open Access
- 8 July 2021
- Published by Wiley in Neural Plasticity
- Vol. 2021, 1-16
Astrocytes in the Ventromedial Hypothalamus Involve Chronic Stress-Induced Anxiety and Bone Loss in Mice
Chronic stress is one of the main risk factors of bone loss. While the neurons and neural circuits of the ventromedial hypothalamus (VMH) mediate bone loss induced by chronic stress, the detailed intrinsic mechanisms within the VMH nucleus still need to be explored. Astrocytes in brain regions play important roles in the regulation of metabolism and anxiety-like behavior through interactions with surrounding neurons. However, whether astrocytes in the VMH affect neuronal activity and therefore regulate chronic stress-induced anxiety and bone loss remain elusive. In this study, we found that VMH astrocytes were activated during chronic stress-induced anxiety and bone loss. Pharmacogenetic activation of the Gi and Gq pathways in VMH astrocytes reduced and increased the levels of anxiety and bone loss, respectively. Furthermore, activation of VMH astrocytes by optogenetics induced depolarization in neighboring steroidogenic factor-1 (SF-1) neurons, which was diminished by administration of N-methyl-D-aspartic acid (NMDA) receptor blocker but not by alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor blocker. These results suggest that there may be a functional “glial-neuron microcircuit” in VMH nuclei that mediates anxiety and bone loss induced by chronic stress. This study not only advances our understanding of glial cell function but also provides a potential intervention target for chronic stress-induced anxiety and bone loss therapy.
- 8 July 2021
- Published by Wiley in Neural Plasticity
- Vol. 2021, 1-16
Open AccessAstrocytes in the Ventromedial Hypothalamus Involve Chronic Stress-Induced Anxiety and Bone Loss in Mice
Chronic stress is one of the main risk factors of bone loss. While the neurons and neural circuits of the ventromedial hypothalamus (VMH) mediate bone loss induced by chronic stress, the detailed intrinsic mechanisms within the VMH nucleus still need to be explored. Astrocytes in brain regions play important roles in the regulation of metabolism and anxiety-like behavior through interactions with surrounding neurons. However, whether astrocytes in the VMH affect neuronal activity and therefore regulate chronic stress-induced anxiety and bone loss remain elusive. In this study, we found that VMH astrocytes were activated during chronic stress-induced anxiety and bone loss. Pharmacogenetic activation of the Gi and Gq pathways in VMH astrocytes reduced and increased the levels of anxiety and bone loss, respectively. Furthermore, activation of VMH astrocytes by optogenetics induced depolarization in neighboring steroidogenic factor-1 (SF-1) neurons, which was diminished by administration of N-methyl-D-aspartic acid (NMDA) receptor blocker but not by alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor blocker. These results suggest that there may be a functional “glial-neuron microcircuit” in VMH nuclei that mediates anxiety and bone loss induced by chronic stress. This study not only advances our understanding of glial cell function but also provides a potential intervention target for chronic stress-induced anxiety and bone loss therapy.
- 1 December 2020
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 130 (12) , 6539-6554
A GABAergic neural circuit in the ventromedial hypothalamus mediates chronic stress–induced bone loss
Homeostasis of bone metabolism is regulated by the central nervous system, and mood disorders such as anxiety are associated with bone metabolism abnormalities, yet our understanding of the central neural circuits regulating bone metabolism is limited. Here, we demonstrate that chronic stress in crewmembers resulted in decreased bone density and elevated anxiety in an isolated habitat mimicking a space station. We then used a mouse model to demonstrate that GABAergic neural circuitry in the ventromedial hypothalamus (VMH) mediates chronic stress–induced bone loss. We show that GABAergic inputs in the dorsomedial VMH arise from a specific group of somatostatin neurons in the posterior region of the bed nucleus of the stria terminalis, which is indispensable for stress-induced bone loss and is able to trigger bone loss in the absence of stressors. In addition, the sympathetic system and glutamatergic neurons in the nucleus tractus solitarius were employed to regulate stress-induced bone loss. Our study has therefore identified the central neural mechanism by which chronic stress–induced mood disorders, such as anxiety, influence bone metabolism.
- 1 December 2020
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 130 (12) , 6539-6554
A GABAergic neural circuit in the ventromedial hypothalamus mediates chronic stress–induced bone loss
Homeostasis of bone metabolism is regulated by the central nervous system, and mood disorders such as anxiety are associated with bone metabolism abnormalities, yet our understanding of the central neural circuits regulating bone metabolism is limited. Here, we demonstrate that chronic stress in crewmembers resulted in decreased bone density and elevated anxiety in an isolated habitat mimicking a space station. We then used a mouse model to demonstrate that GABAergic neural circuitry in the ventromedial hypothalamus (VMH) mediates chronic stress–induced bone loss. We show that GABAergic inputs in the dorsomedial VMH arise from a specific group of somatostatin neurons in the posterior region of the bed nucleus of the stria terminalis, which is indispensable for stress-induced bone loss and is able to trigger bone loss in the absence of stressors. In addition, the sympathetic system and glutamatergic neurons in the nucleus tractus solitarius were employed to regulate stress-induced bone loss. Our study has therefore identified the central neural mechanism by which chronic stress–induced mood disorders, such as anxiety, influence bone metabolism.
- 8 June 2020
- Published by Wiley in Journal of Tissue Engineering and Regenerative Medicine
- Vol. 14 (10) , 1363-1377
Tissue‐engineered parathyroid gland and its regulatory secretion of parathyroid hormone
Parathyroid glands (PTGs) are important endocrine organs being mainly responsible for the secretion of parathyroid hormone (PTH) to regulate the balance of calcium (Ca) /phosphorus (P) ions in the body. Once PTGs get injured or removed, their resulting defect or loss of PTH secretion should disturb the level of Ca/P in blood, thus damaging other related organs (bone, kidney, etc.) and even causing death. Recently, tissue‐engineered PTGs (TE‐PTGs) have attracted lots of attention as a potential treatment for the related diseases of PTGs caused by hypoparathyroidism and hyperparathyroidism, including tetany, muscle cramp, nephrolithiasis, nephrocalcinosis as well as osteoporosis. Although great progress has been made in the establishment of TE‐PTGs with an effective strategy to integrate the key factors of cells and biomaterials, its regulatory secretion of PTH to mimic its natural rhythms in the body remains a huge challenge. This review comprehensively describes an overview of PTGs from physiology and pathology to cytobiology and tissue engineering. The state of the arts in TE‐PTGs and the feasible strategies to regulate PTH secretion behaviors are highlighted to provide an important foundation for further investigation.
- 8 June 2020
- Published by Wiley in Journal of Tissue Engineering and Regenerative Medicine
- Vol. 14 (10) , 1363-1377
Tissue‐engineered parathyroid gland and its regulatory secretion of parathyroid hormone
Parathyroid glands (PTGs) are important endocrine organs being mainly responsible for the secretion of parathyroid hormone (PTH) to regulate the balance of calcium (Ca) /phosphorus (P) ions in the body. Once PTGs get injured or removed, their resulting defect or loss of PTH secretion should disturb the level of Ca/P in blood, thus damaging other related organs (bone, kidney, etc.) and even causing death. Recently, tissue‐engineered PTGs (TE‐PTGs) have attracted lots of attention as a potential treatment for the related diseases of PTGs caused by hypoparathyroidism and hyperparathyroidism, including tetany, muscle cramp, nephrolithiasis, nephrocalcinosis as well as osteoporosis. Although great progress has been made in the establishment of TE‐PTGs with an effective strategy to integrate the key factors of cells and biomaterials, its regulatory secretion of PTH to mimic its natural rhythms in the body remains a huge challenge. This review comprehensively describes an overview of PTGs from physiology and pathology to cytobiology and tissue engineering. The state of the arts in TE‐PTGs and the feasible strategies to regulate PTH secretion behaviors are highlighted to provide an important foundation for further investigation.
- Open Access
Identification of a Central Neural Circuit that Regulates Anxiety-induced Bone Loss
The homeostasis of bone metabolism is finely regulated by the central nervous system and recent studies have suggested that mood disorders, such as anxiety, are closely related to bone metabolic abnormalities; however, our understanding of central neural circuits regulating bone metabolism is still largely limited. In this study, we first demonstrate that confined isolation of human participants under normal gravity resulted in decreased bone density and elevated anxiety levels. We then used an established mouse model to dissect the neural circuitry regulating anxiety-induced bone loss. Combining electrophysiological, optogenetic and chemogenetic approaches, we demonstrate that GABAergic neural circuitry in ventromedial hypothalamus (VMH) modulates anxiety-induced bone loss; importantly, the GABAergic input in VMHdm arose from a specific group of somatostatin neurons in the bed nucleus of the stria terminalis (BNST), which is both indispensable for anxiety-induced bone loss and able to trigger bone loss in the absence of stressors. VGLUT2 neurons in Nucleus tractus solitaries (NTS) and peripheral sympathetic system were employed by this BNST-VMH neural circuit to regulate anxiety-induced bone loss. Overall, we uncovered new GABAergic neural circuitry from the forebrain to hypothalamus, used in the regulation of anxiety-induced bone loss, and revealed a population of somatostatin neurons in BNST not previously implicated in bone mass regulation. These findings thus identify the underlying central neural mechanism of psychiatric disorders, such as anxiety, that influences bone metabolism at the circuit level. One Sentence Summary: Identification of a new GABAergic neural circuit from forebrain to hypothalamus used for regulation of anxiety-induced bone loss.
Open AccessIdentification of a Central Neural Circuit that Regulates Anxiety-induced Bone Loss
The homeostasis of bone metabolism is finely regulated by the central nervous system and recent studies have suggested that mood disorders, such as anxiety, are closely related to bone metabolic abnormalities; however, our understanding of central neural circuits regulating bone metabolism is still largely limited. In this study, we first demonstrate that confined isolation of human participants under normal gravity resulted in decreased bone density and elevated anxiety levels. We then used an established mouse model to dissect the neural circuitry regulating anxiety-induced bone loss. Combining electrophysiological, optogenetic and chemogenetic approaches, we demonstrate that GABAergic neural circuitry in ventromedial hypothalamus (VMH) modulates anxiety-induced bone loss; importantly, the GABAergic input in VMHdm arose from a specific group of somatostatin neurons in the bed nucleus of the stria terminalis (BNST), which is both indispensable for anxiety-induced bone loss and able to trigger bone loss in the absence of stressors. VGLUT2 neurons in Nucleus tractus solitaries (NTS) and peripheral sympathetic system were employed by this BNST-VMH neural circuit to regulate anxiety-induced bone loss. Overall, we uncovered new GABAergic neural circuitry from the forebrain to hypothalamus, used in the regulation of anxiety-induced bone loss, and revealed a population of somatostatin neurons in BNST not previously implicated in bone mass regulation. These findings thus identify the underlying central neural mechanism of psychiatric disorders, such as anxiety, that influences bone metabolism at the circuit level. One Sentence Summary: Identification of a new GABAergic neural circuit from forebrain to hypothalamus used for regulation of anxiety-induced bone loss.